Clinical Evaluation of an AI Risk Prediction System (AI-TRiPS)

NCT07634185 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 1200

Last updated 2026-06-08

No results posted yet for this study

Summary

The goal of this clinical study is to evaluate a software device and its impact on clinician behaviour during the initial management of trauma patients in a real-world clinical setting. Known as the AI-TRiPS Device this software uses real-time prehospital data and machine learning-based risk predictions which are displayed digitally for hospital trauma teams prior patient arrival.

The investigators will use a Stepped Wedge Cluster Randomised Controlled study design with an integrated process evaluation.

The Device will be deployed across the London Major Trauma System where the Major Trauma Centres will be the clusters. Each cluster will transition from control (standard care) to intervention at a pre-specified time (time of transition is randomised).

Primary Outcome: Clinician behaviour, assessed via the accuracy of risk prediction and clinician confidence.

Secondary Outcome: Clinician acceptability, care process metrics, patient outcomes, and safety endpoints.

Primary study population: Hospital trauma clinicians, following initial resuscitation of each eligible trauma patient, who will complete electronic questionnaires.

Secondary study population: Adult trauma patients, data will be collected for the duration of their index admission to hospital, to assess outcomes and enable comparison with clinician risk predictions.

Conditions

Interventions

DEVICE

AI-TRiPS Device

This is Software as a Medical Device designed to function as an aid to inform clinical situational awareness by presenting predictions of patient trajectory (probability of death, probability of trauma induced coagulopathy, probability of red cell transfusion, probability of acute kidney injury).

Sponsors & Collaborators

  • Congressionally Directed Medical Research Programs

    collaborator FED
  • University of Aberdeen

    collaborator OTHER
  • Barts & The London NHS Trust

    collaborator OTHER
  • St George's University Hospitals NHS Foundation Trust

    collaborator OTHER
  • Imperial College Healthcare NHS Trust

    collaborator OTHER
  • King's College Hospital NHS Trust

    collaborator OTHER
  • London Ambulance Service NHS Trust

    collaborator OTHER
  • London's Air Ambulance Charity

    collaborator OTHER
  • Queen Mary University of London

    lead OTHER

Principal Investigators

  • Prof. N Tai · Queen Mary University London

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2027-06-01
Completion
2027-12-01

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07634185 on ClinicalTrials.gov